Improving Quality of Life of Children With Cancer Through Psychosocial Screening
Improving Quality of Life of Children With Cancer Through Psychosocial Screening and Improved Communication in Health Care Providers
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Tipo de estudo
Tipo de estudo
Inscrição (Real)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
British Columbia
-
Vancouver, British Columbia, Canadá
- BC Women and Children's Hospital
-
-
Ontario
-
Toronto, Ontario, Canadá, M5V1X8
- The Hospital for Sick Children
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Parents of children newly diagnosed with cancer, within 2 to 4 weeks post-diagnosis.
- Siblings of children newly diagnosed with cancer, within 2-4 weeks post-diagnosis, between the ages of 8 years and 16 years, able to complete outcome measures, without a physical chronic condition.
- Children with cancer, newly diagnosed, within 2 to 4 weeks post-diagnosis, between the ages of 8 and 16 years, able to complete outcome measures.
Exclusion Criteria:
- Parents of children not diagnosed with cancer.
- Sibling of children not diagnosed with cancer
- Children not diagnosed with cancer.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Experimental Group
Participants in this arm will have a summary of their family's psychosocial risk factors provided to the treatment team.
This will occur twice: once shortly after diagnosis (within 2-4 weeks) and once approximately 6 months following diagnosis.
|
The treatment team will receive a psychosocial risk summary shortly following diagnosis based on parent report.
|
|
Comparador Ativo: Control Group
Participants in this arm will NOT have a summary of their family's psychosocial risk factors provided to the treatment team shortly after diagnosis.
However, the risk factors will be distributed to the treatment team 6 months following diagnosis.
|
The treatment team will NOT receive a psychosocial risk summary shortly following diagnosis based on parent report.
|
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline psychological distress at pediatric cancer diagnosis to six months later
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Measured by Hospital Anxiety and Depression Scale (HADS).
A standardized measure of symptoms of anxiety and depression in adults.
The HADS is suitable for all ages from 17+.
The HADS consists of 14 questions, which are ranked according to a 4 point Likert type scale.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline quality of life at pediatric cancer diagnosis to six months (Parent Self-Report)
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Measured by Caregiver Quality of Life Scale (CQOLC), 35 items using a five-point Likert-type scale to assess QoL in the family caregiver of cancer patients.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
|
Change from baseline distress at pediatric cancer diagnosis to six months following
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Measured by the Distress Thermometer, a standardized screening tool for measuring emotional distress in adults.
Has been widely used as a screening tool of distress in adult cancer patients and caregivers.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
|
Change from baseline family climate at pediatric cancer diagnosis to six months
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Measured by Family Environment Scale (FES), a standardized measure of social climate within the family.
The FES is a self-report measure which contains 27 true/false statements.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
|
Change from baseline quality of life at pediatric cancer diagnosis to six months (Self) report
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Measured by Pediatric Quality of Life (PedsQL 4.0) - Cancer Module, Standardized tool measures child/parent perceptions of a child's health-related quality of life specific to having cancer.
Self report and parent proxy perception of health-related quality of life across 8 domains: pain, nausea, procedure, and treatment anxiety, worry, cognition, physical and commutation.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
|
Change from baseline quality of life at pediatric cancer diagnosis to six months (Proxy Report)
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Measured by Pediatric Quality of Life (PedsQL 4.0) - Generic Module.The measure assesses perception for the child's general health across global, physical, emotional , social and academic domains.
Parent/self report by healthy sibling
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
|
Pediatric Distress Thermometer
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Standardized screening tool for measuring emotional distress in children.
The distress thermometer adapted for pediatric population.
Participants self-report on their distress on a line drawing representation of a thermometer.
For this age group, distress is defined as worry, anxiety, sadness and fear on a visual analog scale from 0 (no distress) to 5 (moderate distress) to 10 (high distress).
For patient with cancer and healthy sibling.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
|
Pediatric Index of Emotional Distress (PI-ed)
Prazo: T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
A 14-item self-report measure of emotional distress in children rated on a 4-point Likert scale (0 = not at all; 3 = always).
This measure, based on the Hospital Anxiety and Depression Scale (HADS;[62]), was designed to differentiate symptoms of emotional distress from physical illness in pediatric populations.
It comprises two subscales assessing depression and anxiety, which when summated, provides a global index of emotional distress.
For child with Cancer and healthy sibling.
|
T1 (2-4 weeks following pediatric cancer diagnosis); T2 (6 months following diagnosis)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Maru Barrera, PhD, The Hospital for Sick Children
Publicações e links úteis
Publicações Gerais
- Barrera M, D'Agostino NM, Gibson J, Gilbert T, Weksberg R, Malkin D. Predictors and mediators of psychological adjustment in mothers of children newly diagnosed with cancer. Psychooncology. 2004 Sep;13(9):630-41. doi: 10.1002/pon.765.
- Boman K, Lindahl A, Bjork O. Disease-related distress in parents of children with cancer at various stages after the time of diagnosis. Acta Oncol. 2003;42(2):137-46. doi: 10.1080/02841860310004995.
- Kazak AE, Simms S, Rourke MT. Family systems practice in pediatric psychology. J Pediatr Psychol. 2002 Mar;27(2):133-43. doi: 10.1093/jpepsy/27.2.133.
- Sawyer MG, Antoniou G, Toogood I, Rice M, Baghurst PA. A prospective study of the psychological adjustment of parents and families of children with cancer. J Paediatr Child Health. 1993 Oct;29(5):352-6. doi: 10.1111/j.1440-1754.1993.tb00533.x.
- Wijnberg-Williams BJ, Kamps WA, Klip EC, Hoekstra-Weebers JE. Psychological distress and the impact of social support on fathers and mothers of pediatric cancer patients: long-term prospective results. J Pediatr Psychol. 2006 Sep;31(8):785-92. doi: 10.1093/jpepsy/jsj087. Epub 2005 Oct 26.
- Woodgate RL, Degner LF, Yanofsky R. A different perspective to approaching cancer symptoms in children. J Pain Symptom Manage. 2003 Sep;26(3):800-17. doi: 10.1016/s0885-3924(03)00285-9.
- Kupst MJ, Natta MB, Richardson CC, Schulman JL, Lavigne JV, Das L. Family coping with pediatric leukemia: ten years after treatment. J Pediatr Psychol. 1995 Oct;20(5):601-17. doi: 10.1093/jpepsy/20.5.601.
- Kazak AE, Brier M, Alderfer MA, Reilly A, Fooks Parker S, Rogerwick S, Ditaranto S, Barakat LP. Screening for psychosocial risk in pediatric cancer. Pediatr Blood Cancer. 2012 Nov;59(5):822-7. doi: 10.1002/pbc.24166. Epub 2012 Apr 10.
- Barrera M, Hancock K, Rokeach A, Cataudella D, Atenafu E, Johnston D, Punnett A, Nathan PC, Bartels U, Silva M, Cassidy M, Jansen P, Shama W, Greenberg C. External validity and reliability of the Psychosocial Assessment Tool (PAT) among Canadian parents of children newly diagnosed with cancer. Pediatr Blood Cancer. 2014 Jan;61(1):165-70. doi: 10.1002/pbc.24774. Epub 2013 Sep 17.
- Patel SK, Mullins W, Turk A, Dekel N, Kinjo C, Sato JK. Distress screening, rater agreement, and services in pediatric oncology. Psychooncology. 2011 Dec;20(12):1324-33. doi: 10.1002/pon.1859. Epub 2010 Oct 5.
- Barrera M, Young MA, Hancock K, Chung J. Early trajectory of psychosocial risk in families of children and adolescents newly diagnosed with cancer. Support Care Cancer. 2022 Feb;30(2):1815-1822. doi: 10.1007/s00520-021-06581-3. Epub 2021 Oct 4.
- Barrera M, Alexander S, Atenafu EG, Chung J, Hancock K, Solomon A, Desjardins L, Shama W, Mills D. Psychosocial screening and mental health in pediatric cancer: A randomized controlled trial. Health Psychol. 2020 May;39(5):381-390. doi: 10.1037/hea0000825. Epub 2020 Jan 23.
- Barrera M, Hancock K, Atenafu E, Alexander S, Solomon A, Desjardins L, Shama W, Chung J, Mills D. Quality of life in pediatric oncology patients, caregivers and siblings after psychosocial screening: a randomized controlled trial. Support Care Cancer. 2020 Aug;28(8):3659-3668. doi: 10.1007/s00520-019-05160-x. Epub 2019 Dec 6.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Real)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
Outros números de identificação do estudo
- 702843
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .